GlassScriptPhysician profile
Younan Nowzaradan
NPI 1861477150
$12,501.15
in general payments reported to CMS, 2019-2025
22 companies · $192 in 2025
The $192 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,222 · 2020: $7,133 · 2021: $1,193 · 2022: $283 · 2023: $233 · 2024: $245 · 2025: $192.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $671.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $670.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,761.54 | 2019-2025 | |
| Medline Industries LP | $434.59 | 2019 | |
| Abbvie INC. | $240.09 | 2022-2023 | |
| Teleflex LLC | $209.48 | 2023-2024 | Titan Sgs, Titan Sgs Standard Gastric Stapler |
| Endo Pharmaceuticals INC. | $142.19 | 2019-2022 | |
| Cumberland Pharmaceuticals, INC. | $123.54 | 2022-2024 | Kristalose |
| Takeda Pharmaceuticals U.S.A., INC. | $116.16 | 2022-2023 | Gattex |
| Ethicon US, LLC | $89.06 | 2019 | |
| Covidien LP | $72.33 | 2019 | |
| Smith+Nephew, INC. | $46.43 | 2019-2021 | |
| Innocoll Pharmaceuticals Limited | $41.90 | 2021 | |
| Currax Pharmaceuticals LLC | $31.78 | 2025 | Contrave |
| Lexington Medical, INC. | $25.19 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Boston Scientific Corporation | $23.66 | 2023 | Resolution 360 Clip |
| Integra Lifesciences Corporation | $23.49 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tei Biosciences INC | $22.45 | 2019 | |
| Intra-Sana Laboratories | $20.73 | 2024 | Reltone 400 Mg, Glycate, Reltone 200 Mg |
| Aesculap, INC. | $18.09 | 2021 | |
| Lilly USA, LLC | $16.49 | 2024 | Zepbound, Jardiance |
| Acell, INC. | $15.70 | 2019 | |
| Convatec INC. | $13.14 | 2019 | |
| Coopersurgical, INC. | $13.12 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Younan Nowzaradan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.